PAR
Click for more information
0.00% 21.0¢ paradigm biopharmaceuticals limited..

MOZZ Research - First Half 2021, page-38

  1. Denial
    9,862 Posts.
    lightbulb Created with Sketch. 1274
    clock Created with Sketch.
    22/07/21
    12:58
    Post #: 54690419
    Perhaps the fact that they have approved Adequan in the US has meant the merits of PPS in treating OA hasn't been well publicised or understood by vets. Where PPS is approved for veterinary use it's a completely different matter
    PAR Price at posting: $2.05 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Ground-breaking works set to begin at Speewah Fluorite Project following cultural heritage clearance and water licence approval
right-arrow Created with Sketch.
NEWS High-grade lithium uncovered at Orrvik, Sweden with 11.55m at 1.45% Li2O including 3m at 3.11% Li2O from surface
right-arrow Created with Sketch.
NEWS Exploration drilling kicks off at Truncheon & Highway East, targeting copper-gold near historic mine
right-arrow Created with Sketch.
NEWS Thick copper, zinc, silver, and gold mineralisation uncovered at Havilah in Lachlan Fold Belt drilling
right-arrow Created with Sketch.
NEWS NRW Holdings inks $109M deal with BHP for works at Jimblebar
right-arrow Created with Sketch.
NEWS High-grade gold-antimony drilling set to resume at Nagambie Mine in November
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
21.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $73.55M
Open High Low Value Volume
21.0¢ 22.0¢ 20.5¢ $222.5K 1.035M

Buyers (Bids)

No. Vol. Price($)
5 77810 21.0¢
 

Sellers (Offers)

Price($) Vol. No.
22.0¢ 23000 2
View Market Depth
Last trade - 16.10pm 11/10/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.